Companies in #Point-of-Care Diagnostics
Found 2 companies operating in this sector.
Intelligent Bio Solutions (formerly GBS Inc.) is a New York-based medical technology company developing intelligent, rapid, non-invasive diagnostic screening built on fingerprint sweat analysis. Its Intelligent Fingerprinting Drug Screening System detects drug use from fingerprint sweat in minutes without sample handling, and the company is advancing an FDA 510(k) submission for U.S. market entry, anchored by codeine-detection studies including an Interference Study and a multi-site Method Comparison Study completed in August 2026. The company also develops a biosensor platform and serves workplace, clinical, and corrections screening markets across the U.S., U.K., and Asia Pacific.
Trinity Biotech plc is a commercial-stage biotechnology company headquartered in Dublin, Ireland, focused on human diagnostics and diabetes management solutions including wearable biosensors. The company develops, acquires, manufactures, and markets diagnostic systems for the point-of-care and clinical laboratory segments and has expanded into the wearable biosensor and data-center liquid-cooling infrastructure segments through recent acquisitions. Trinity Biotech is dual-listed on Nasdaq and announced a 1-for-30 reverse ADS split in July 2026 intended to regain Nasdaq minimum-bid-price compliance.